vision loss
Annexin Pharmaceuticals: Can ANXV replace anti-VEGFs?
Annexin Pharmaceuticals is developing the drug candidate ANXV in the eye disease retinal vein occlusion, RVO, and in cancer. The company recently released phase IIa topline results...
Intervju
Video
Intensive Q4 leads Annexin into interesting 2023
Intense and significant – that's how Annexin Pharmaceuticals describes...